Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer

Clinical trial NCT06470282 · RECRUITING

Trial details

NCT number: NCT06470282
Sponsor: University of California, San Francisco
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Muscle-Invasive Bladder Carcinoma Stage II Bladder Cancer AJCC v8 Stage IIIA Bladder Cancer AJCC v8

Start date: 2025-03-31
Primary completion: 2028-01-31
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.